Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12429617 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn 18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
Conditions: Carcinoma, Non-Small-Cell Lung;   Thymus Neoplasms
Interventions: Drug: 3'-deoxy-3'-18F fluorothymidine (FLT);   Other: PET/CT scan
2 Active, not recruiting Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient
Conditions: Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent;   No EGFR Activating Mutation
Interventions: Radiation: 18F-FLT-TEP;   Radiation: 18F-FDG-TEP

Indicates status has not been verified in more than two years